Background：Anetumab ravtansine, also known as BAY 94-9343, is a novel, selective and highly potent antibody-drug conjugate consisting of a human anti-mesothelin antibody conjugated to the maytansinoid tubulin inhibitor DM4 via a disulfide-containing linker a reducible SPDB linker [N-succinimidyl 4- 2-pyridyldithiobutanoate] on an average of 3 lysyl.
Alternative Names：BAY 94-9343, BAY 86-1903, BAY 2287409, Anetumab Ravtansine,
